Vanguard Group
TTNP icon

Vanguard Group’s Titan Pharmaceuticals TTNP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-82,051
Closed -$33.8K 4483
2023
Q4
$33.8K Hold
82,051
﹤0.01% 4402
2023
Q3
$38.9K Hold
82,051
﹤0.01% 4441
2023
Q2
$53K Hold
82,051
﹤0.01% 4450
2023
Q1
$68.1K Hold
82,051
﹤0.01% 4438
2022
Q4
$64.3K Buy
82,051
+127
+0.2% +$99 ﹤0.01% 4424
2022
Q3
$88K Buy
81,924
+7,029
+9% +$7.55K ﹤0.01% 4505
2022
Q2
$42K Sell
74,895
-131,533
-64% -$73.8K ﹤0.01% 4596
2022
Q1
$197K Hold
206,428
﹤0.01% 4538
2021
Q4
$210K Sell
206,428
-267
-0.1% -$272 ﹤0.01% 4553
2021
Q3
$386K Buy
206,695
+2,371
+1% +$4.43K ﹤0.01% 4414
2021
Q2
$531K Buy
204,324
+131,533
+181% +$342K ﹤0.01% 4263
2021
Q1
$217K Buy
72,791
+16,100
+28% +$48K ﹤0.01% 4249
2020
Q4
$186K Sell
56,691
-1,094,212
-95% -$3.59M ﹤0.01% 4094
2020
Q3
$190K Hold
1,150,903
﹤0.01% 3959
2020
Q2
$352K Hold
1,150,903
﹤0.01% 3843
2020
Q1
$268K Buy
1,150,903
+1,029,073
+845% +$240K ﹤0.01% 3816
2019
Q4
$24K Sell
121,830
-421,176
-78% -$83K ﹤0.01% 4081
2019
Q3
$146K Sell
543,006
-39,174
-7% -$10.5K ﹤0.01% 3994
2019
Q2
$746K Buy
582,180
+109,016
+23% +$140K ﹤0.01% 3749
2019
Q1
$842K Sell
473,164
-1,709,643
-78% -$3.04M ﹤0.01% 3672
2018
Q4
$487K Buy
2,182,807
+1,750,470
+405% +$391K ﹤0.01% 3739
2018
Q3
$90K Buy
432,337
+48,760
+13% +$10.2K ﹤0.01% 4089
2018
Q2
$418K Sell
383,577
-1,151
-0.3% -$1.25K ﹤0.01% 3852
2018
Q1
$404K Buy
384,728
+12,115
+3% +$12.7K ﹤0.01% 3825
2017
Q4
$494K Sell
372,613
-99,582
-21% -$132K ﹤0.01% 3751
2017
Q3
$827K Sell
472,195
-192,340
-29% -$337K ﹤0.01% 3638
2017
Q2
$1.26M Sell
664,535
-43,208
-6% -$82.1K ﹤0.01% 3522
2017
Q1
$2.34M Buy
707,743
+15,319
+2% +$50.5K ﹤0.01% 3337
2016
Q4
$2.77M Buy
692,424
+64,313
+10% +$257K ﹤0.01% 3250
2016
Q3
$3.69M Buy
628,111
+59,036
+10% +$347K ﹤0.01% 3146
2016
Q2
$3.11M Buy
569,075
+266,641
+88% +$1.46M ﹤0.01% 3198
2016
Q1
$1.45M Buy
302,434
+268,834
+800% +$1.29M ﹤0.01% 3486
2015
Q4
$149K Buy
+33,600
New +$149K ﹤0.01% 4044